Neurobiol Dis., 2015 · DOI: 10.1016/j.nbd.2014.10.024 · Published: February 1, 2015
After a spinal cord injury, scar tissue forms, which includes glial and fibrotic components. This scar tissue can prevent axon regeneration and limit immune cell infiltration. The study found that macrophages, specifically those originating from the blood (hematogenous), are responsible for recruiting fibroblasts to the injury site, which contributes to fibrotic scar formation. Depleting these hematogenous macrophages reduces fibroblast recruitment, promotes axonal growth into the injured area, and alters cytokine expression, making the injury site less fibrotic and more conducive to nerve regeneration.
Targeting hematogenous macrophages could be a potential therapeutic strategy to reduce fibrotic scarring and promote axonal regeneration after spinal cord injury.
Modulating cytokine expression, specifically decreasing Tnfsf8/Tnfsf13 and increasing BMP1-7, may enhance the regenerative potential of the injured spinal cord.
Combining macrophage depletion with other regenerative strategies may lead to improved functional outcomes after SCI.